Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2000 Sep-Oct;31(5):400-10.

Prospective randomized comparison of simultaneous and sequential bilateral photorefractive keratectomy for the correction of myopia

Affiliations
  • PMID: 11011709
Clinical Trial

Prospective randomized comparison of simultaneous and sequential bilateral photorefractive keratectomy for the correction of myopia

M Vetrugno et al. Ophthalmic Surg Lasers. 2000 Sep-Oct.

Abstract

Background and objective: To evaluate the efficacy and safety of simultaneous bilateral photorefractive keratectomy (PRK).

Patients and methods: There were 52 patients (104 eyes) with myopia less than -6 diopters entered in this prospective trial and randomized to simultaneous or sequential bilateral PRK. Main outcome measures were uncorrected visual acuity (UCVA), percentage of eyes within +/-0.5 D of attempted outcome, present pain intensity (PPI) and total pain rating index (PRI(R)T) scores resulting from McGill the Pain Questionnaire, subjective symptoms, haze, and patient satisfaction. Follow-up extended to 14 months.

Results: There was no significant difference in UCVA (P=0.996) and percentage of eyes within +/-0.5 D of attempted correction (P=0.932). Present pain intensity and PRI(R)T scores were significantly higher in the sequential group (P=0.037; P=0.034). The percentage of satisfied patients after bilateral PRK was significantly higher in the simultaneous group (P=0.036).

Conclusions: Simultaneous bilateral PRK was safe and effective, without any significant difference from sequential treatment.

PubMed Disclaimer

LinkOut - more resources